Fort Myers, Florida, 18 April 2024 — MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technology to lead life sciences, is proud to announce that its DNBSEQ-T20x2* gene sequencer has been recognized with a Gold Edison Award in the “Health, Medical & Biotech” category.
“MGI is dedicated to unlocking the future of genomic technologies and pursuing excellence in building life science core tools,” said Duncan Yu, President of MGI. “It is our pleasure and honour to be awarded the Edison Award for the first time. This recognition affirms our team’s efforts in intelligent innovation as we continue to achieve outstanding results on the global stage.”
Named after the prolific inventor Thomas A. Edison, the Edison Awards are among the most prestigious technology accolades, honouring excellence in new product development, design, and innovation. Thousands of innovations from around the world were reviewed by senior scientists, designers, engineers, marketers, and leading academics based on the four criteria of concept, value, delivery, and impact. The “Health, Medical & Biotech” category, in particular, recognises products and services that have made a profound impact on patients and healthcare providers.
MGI’s ground-breaking DNBSEQ-T20x2* ultra-high-throughput sequencer has been garnering significant attention since its debut in February 2023 for reducing genome sequencing costs to less than $100 per genome. This remarkable feat not only facilitates sequencing of a larger number of samples, but also enables more comprehensive, insightful, and precise analysis per sample.
The commercial success of DNBSEQ-T20x2* has enhanced overall sequencing capabilities and accelerated global scientific advances by doubling the efficiency of DNA sequencing. With its unparalleled throughput and exceptional cost-effectiveness, the sequencer is contributing to the development of the global genetic industry and driving progress in understanding the human genome and various medical applications.
Since its introduction, DNBSEQ-T20x2* has been received positively by leading global research institutions and healthcare providers, with corporate orders from Shanghai-based JMDNA Biomedical Technology Co., Ltd., Prepaire Labs, a healthcare technology company in Abu Dhabi, and Eurofins Genomics, one of the key emerging players in specialty esoteric and molecular clinical diagnostic testing in Europe and the United States.
About Edison Awards™
Established in 1987, the Edison Awards are dedicated to recognising, honouring, and fostering innovations and innovators. Named after Thomas Alva Edison (1847–1931), the annual competition celebrates excellence in new product and service development, marketing, design, and innovation. Past award recipients include Steve Jobs, Elon Musk, and leaders of global corporations such as Coca-Cola, Genentech, General Electric, General Motors, IBM, and Campbell Soup Co.
In 2021, the Edison Awards introduced the inaugural Lewis Latimer Fellowship program, designed to celebrate, connect, and bring together a community of innovative Black thought leaders. For more information, visit www.edisonawards.com
